*rate hikes Wednesday not Thursday.
50bps could temporarily boost stocks. I think though very short lived as inflation worries persist.
If we truly entering a recession we can write off any and all investments for at least a year...Unless you invest in beverages ( ideally with lots of alcohol)
Nothing left to say here. Seems like ONC is impacted by CPI data just as much as any other Business. Fed rate hikes announcement Thursday should hopefully not come with a 75basis points shocker. Sure this baby will grow. Just a rubbish time in the markets.
I dumped way too much money into this stock. Would I top up more if I could? Probably. But that's just because I am really foolish. A fool for Oncimmune
YoY growth seems to be great so far. It doesn't really matter too much where the money comes from, at the end of the day what matters is that they can demonstrate an ROI and hopefully that won't be blurred by more debt/credit/loan they take on. A fine line to be treaded as we approach profitability. You want to expand fast enough to enjoy the momentum, but you want to maintain a healthy cash flow to debt position.
"Gross cash balance at the period end of £2.97M (H1 2021: £3.28M) and net debt at the period end of £5.39M (H1 2021: £7.22M), after investment including capacity growth. The Company drew down an additional €3.0M (c.£2.50M) of debt post period end to fund the acceleration in the expansion of the US-based Commercial team, serviceable by cash generation from ImmunoINSIGHTS."
Just need to make sure we get to a point where net debt gets smaller and that funding can indeed come from revenues in immunoinsights (and also EarlyCDT)
I just want to confirm with anyone here that is knowlegeable. How long was the 8mio GBP funding supposed to last?
My concern is that if ONC run out of cash too fast and ask for more funding, it could seriously dent the SP again for a while.
Topped up yesterday and today. Should see this one recover soon. Bear market already lasted almost 200days, which by all accounts is a typical timeframe for sentiment to switch into a more positive direction. I think a little news on ONC would be welcome. Just a little update to keep us distracted from the other RNS. We need s9me good news to talk about ^^
I for one am going nowhere until i got my fair share back. I find it somewhat laughable that a UBS would try to lower average on a stock that has 5-10 trades a day on average and is traded on AIM. You would think that this would be a lomger term thing for them too. Maybe they put a Rookie to the task.
From my owm research i am quite convinced that ONC is a good investment but we need to see good results and strong growth forecast. I also expect management to stick to not requiring additional funding for the coming year at least.
My hope is that they can finally realize that missing revenue from last annual report. The US sales team would have had almost a 6month ramp - time to close those big deals. We will see much higher personnel cost in September due to these hires, so hopefully that wont squeeze the sheet too much.
NHS progress seems to be super slow but needs to drop at some point. But honestly with hospitals back to full capacity i would expect there to be enough time and room to focus on delivering that.
What is the forecasted revenue for this year? 12.x mio? We are trading just shy of 5x if that were the figure. I would say its time to get moving here.
When does ONC expect to be profitable? 2025?
Lets see
Put my neck out there and purchased some more. ISA needs filling and i have other less attractive stocks that i pulled out of now #IAG what a disaster. If we are truly at the brink of a global financial collapse, what does it matter anyway.
20x would actually put me slightly above my overall average. The report does give some comfort. But far from the big ticket that stock promises to be. No doubt this organisation has an amazing journey ahead especially with Adam's leadership. I am just looking out for my investment too.
Looks like we need to put our arms down until the market picks up again. Noone wants to miss the boat when the SP does spike. When that may be is anyone's guess by the looks of it. But with intensified rate hikes by the federal reserve to combat a soaring inflation, general supply constraints and some rather big failures in drug development as of recent I would say that it would be best advised to take a holiday and come back to this in mid 2023. By that point I would be gobsmacked if ONC were not bought up at its truely laughable SP. Sure they are in debt but not for long. And their technology is proven to work and to turn around revenue. I hope that the next report will do something to up the price but honestly I feel like this is an old hymn that I have been singing. Lightweight84 might have had a good point in exiting when he did, albeit for the wrong reasons.
We can hold on until numbers are released in September but don't hold your breath. A takeover now would put me out of pocket....big time
Track Your Investments
Register for FREE